As a heterogeneous group of diseases, BC can be classified into various subtypes based on the expression levels of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and proliferation cell nuclear antigen (Ki67). This evidence concerns the gene PGR and breast cancer.